Central Michigan University is a clinical research site located in Detroit, Michigan, United States 48201.
Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.
Central Michigan University has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Haemophilia A, Haemophilia A With Inhibitors, Neonatal Opioid Withdrawal Syndrome.
Sponsors: Novo Nordisk A/S, Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program, Parth Patel.
Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Central Michigan University has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Central Michigan University has 4 clinical trials on record, with 3 currently active. Their work covers Haemophilia A, Haemophilia A With Inhibitors, Neonatal Opioid Withdrawal Syndrome.
Central Michigan University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.